VC Deals (7 deals, $120M) ObsEva, a Swiss developer of drugs that address “serious conditions compromising pregnancy from conception to birth,” has raised around $60 million in Series B funding. [...]
VC Deals (12 deals, $280M) Personal Genome Diagnostics, a Baltimore-based provider of advanced cancer genome testing products and services, raised $21.4 million in a Series A funding round led by [...]
VC Deals (11 deals, $340M) Verisma Systems, a Pueblo, Colo.-based provider of “release of information” services to healthcare organizations, has raised $14.55 million in growth equity funding [...]
VC Deals (12 deals, $109M raised) TAI Diagnostics Inc., a Wauwatosa, Wis.-based developer of diagnostic tests for monitoring the health of transplanted organs, has raised $8.2 million in Series A [...]
VC Deals (14 deals, $480M) HealthiPASS, a Chicago-based patient check-in and payments company, has raised an undisclosed amount of Series A funding. OCA Ventures led the round, and was joined by [...]
VC Deals Doctolib, a French platform for booking doctor appointments, has raised €18 million in Series B funding led by Accel Partners FabFitFun, a Los Angeles-based “lifestyle brand inspiring [...]
VC Deals Apitope, a Belgium-based drug developer focused on “treating the underlying cause of autoimmune diseases,” has raised €12 million in Series B funding.Wales Life Sciences Fund led the [...]
VC Deals Deciphera Pharmaceuticals, a Waltham, Mass.-based developer of kinase inhibitor treatments targeting tumors cells, has raised $75 million in Series B funding led by New Leaf Venture [...]